Invest now

Suven Life Sciences Cash Flow Annual

BSE: 530239 | NSE: SUVEN | ISIN: INE495B01038 | Sector: Biotechnology & Drugs
280.75 +2.75 (0.99%)Updated : 12 Nov 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Issuance( Retirement)of Debt Net -0.37-0.71-0.90-1.60
Net Changein Cash -6.750.09-22.0931.75
Cash Taxes Paid 0.76-0.61-6.181.10
Net Income/ Starting Line -276.34-160.75-106.08-118.27
Changesin Working Capital -19.0910.6713.0710.38
Cashfrom Operating Activities -301.41-154.10-115.47-103.15
Cashfrom Financing Activities 756.78-0.76-1.05395.54
Issuance( Retirement)of Stock Net 755.98--397.40
Depreciation/ Depletion 5.615.315.825.83
Other Investing Cash Flow Items Total -457.03192.2394.44-257.75
Capital Expenditures -5.08-37.28--2.89
period Type ----
Non- Cash Items -11.60-9.34-28.27-1.09
Financing Cash Flow Items 1.18-0.05-0.16-0.26
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -462.11154.9594.44-260.65
Cash Interest Paid -0.050.160.26
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,111.30+36.30(3.38%)
1,893.60+38.60(2.08%)
1,077.75+17.55(1.66%)
1,975.40-44.60 (-2.21%)